Rapid induction of uterine tumors with p53 point mutations in heterozygous p53-deficient CBA mice given a single intraperitoneal administration of N-ethyl-N-nitrosourea.

To investigate the sensitivity of heterozygous p53-deficient CBA mice to carcinogens, 20 female mice [p53(+/-)] and 20 wild-type littermates [p53(+/+)] were given an intraperitoneal injection of 120 mg/kg body wt of N-ethyl-N-nitrosourea (ENU) and were maintained without any other treatment for a further 26 weeks. Histopathology showed that uterine tumors (endometrial polyps and stromal sarcomas) and lung adenomas were induced in both p53(+/-) and p53(+/+) mice. The incidence of uterine tumors and lung adenomas (94% and 81%, respectively) in p53(+/-) mice was significantly greater than that in p53 (+/+) mice (37% and 42%, respectively). Malignant lymphomas were only induced in p53(+/-) mice, at an incidence of 31%. Concerning uterine tumors and preneoplastic lesions, there were endometrial stromal sarcomas and atypical hyperplasias of the endometrial gland in 90% and 63%, respectively, of p53(+/-) mice, with significantly greater incidences than in p53(+/+) mice. Gene analysis revealed GCG-->GTG point mutations in codon 135 of exon 5 of the p53 allele in all of the uterine endometrial stromal sarcomas examined. Our results suggest that female p53(+/-) CBA mice are very susceptible to uterine carcinogenesis, providing a useful model for ENU-induced uterine tumors.

[1]  Midori Yoshida,et al.  Uterine Carcinogenesis by Chemicals/Hormones in Rodents. , 1999 .

[2]  S. Fukushima,et al.  High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele. , 1998, Cancer research.

[3]  T. Devereux,et al.  Predominant p53 G→A Transition Mutation and Enhanced Cell Proliferation in Uterine Sarcomas of CBA Mice Treated with 1,2-Dimethylhydrazine , 1998, Toxicologic pathology.

[4]  S. Stasiewicz,et al.  Phenolphthalein Induces Thymic Lymphomas Accompanied by Loss of the p53 Wild Type Allele in Heterozygous p53-Deficient (±) Mice , 1997, Toxicologic pathology.

[5]  S. Mai,et al.  Genomic instability and apoptosis are frequent in p53 deficient young mice , 1997, Oncogene.

[6]  S. Aizawa,et al.  Loss of p53 is an early event in induction of brain tumors in mice by transplacental carcinogen exposure. , 1997, Cancer research.

[7]  R. Tennant,et al.  Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens. , 1996, Mutation research.

[8]  M. Oren,et al.  Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion. , 1996, Oncogene.

[9]  H. Yonekawa,et al.  Mutational and LOH analyses of p53 alleles in colon tumors induced by 1,2-dimethylhydrazine in F1 hybrid mice. , 1995, Carcinogenesis.

[10]  S. Hirohashi,et al.  Prognostic Value of p53 Protein Accumulation in Cancer Cell Nuclei in Adenocarcinoma of the Uterine Cervix , 1995, Japanese journal of cancer research : Gann.

[11]  R. Tennant,et al.  Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. , 1995, Environmental health perspectives.

[12]  Carissa A. Sanchez,et al.  A p53-dependent mouse spindle checkpoint , 1995, Science.

[13]  L. Hartwell,et al.  Cell cycle control and cancer. , 1994, Science.

[14]  Masatoshi Watanabe,et al.  p53 Gene Mutations in Human Prostate Cancers in Japan: Different Mutation Spectra between Japan and Western Countries , 1994, Japanese journal of cancer research : Gann.

[15]  J. Marx.  How p53 suppresses cell growth. , 1993, Science.

[16]  T. Yagi,et al.  Enhanced proliferative potential in culture of cells from p53-deficient mice. , 1993, Oncogene.

[17]  G. Wahl,et al.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles , 1992, Cell.

[18]  P. Clement,et al.  Endometrial Stromal Sarcomas of the Uterus With Extensive Endometrioid Glandular Differentiation: A Report of Three Cases That Caused Problems in Differential Diagnosis , 1992, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[19]  A. Kung,et al.  Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia. , 1992, Cancer research.

[20]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[21]  T. Sugimura,et al.  Frequent association of p53 gene mutation in invasive bladder cancer. , 1992, Cancer research.

[22]  J. Cunningham,et al.  Pattern of p53 gene mutations in breast cancers of women of the midwestern United States. , 1992, Journal of the National Cancer Institute.

[23]  Takuji Tanaka,et al.  Rapid Induction of Endometrial Carcinoma in ICR Mice Treated with N‐Methyl‐N‐nitrosourea and 17β‐Estradiol , 1991, Japanese journal of cancer research : Gann.

[24]  S. Hirohashi,et al.  Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. , 1991, Cancer research.

[25]  J. Marks,et al.  Maintenance of p53 alterations throughout breast cancer progression. , 1991, Cancer research.

[26]  H. Meden,et al.  Endometrial stromal sarcoma of the uterus , 1991, Anti-Cancer Drugs.

[27]  J. Marks,et al.  Maintenance of p 53 Alterations throughout Breast Cancer Progression 1 , 1991 .

[28]  R Montesano,et al.  Frequent mutation of the p53 gene in human esophageal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[30]  J. Minna,et al.  p53: a frequent target for genetic abnormalities in lung cancer. , 1989, Science.

[31]  B W Glickman,et al.  Influence of neighboring base sequence on the distribution and repair of N-ethyl-N-nitrosourea-induced lesions in Escherichia coli. , 1988, Cancer research.

[32]  T R Skopek,et al.  DNA base changes and alkylation following in vivo exposure of Escherichia coli to N-methyl-N-nitrosourea or N-ethyl-N-nitrosourea. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Russell.  Histological Typing of Female Genital Tract Tumours , 1977 .

[34]  K. Rao,et al.  Development of broad spectrum of tumors by ethylnitrosourea in mice and the modifying role of age, sex, and strain. , 1974, Cancer research.

[35]  P. Magee,et al.  Carcinogenic nitroso compounds. , 1967, Advances in cancer research.

[36]  M. Hollstein,et al.  Frequent mutation of the p 53 gene in human esophageal cancer ( tumor suppressor gene / DNA sequence analysis / nitrosamines ) , 2022 .